Tumors screening package for Men - Early Detection of Tumors and General Health Monitoring

What the package contains:

Alpha-Fetoprotein (AFP):
A test used for detecting liver tumors and some other tumors such as reproductive system tumors.
Elevated levels may indicate liver issues or cancerous tumors.

CA 15.3:
A test used to detect reproductive system tumors or monitor certain types of tumors, especially those related to soft tissues.

CA 19.9:
An indicator for detecting cancer of the pancreas, liver, or gallbladder.
It helps in assessing the health of the digestive system and monitoring tumor development if present.

Carcinoembryonic Antigen (CEA):
A test used to detect cancerous tumors in the colon, rectum, lungs, and stomach.
It also helps in monitoring the effectiveness of treatment or following up on patients who have been previously treated.

PSA Total (Prostate-Specific Antigen):
A test designed for the early detection of prostate cancer or monitoring known cases.
This test is considered one of the most important for men to maintain prostate health.

What does this package provide?

Early detection of common cancers in men.
Monitoring of tumor development or response to treatment.
Assessment of liver, gastrointestinal, and reproductive system health.
Assisting the doctor in developing a treatment or preventive plan based on the results.

Who is this package suitable for?

Men with a family history of cancerous tumors.
Those experiencing symptoms such as unexplained fatigue, rapid weight loss, or changes in body functions.
Men over the age of 40, especially for monitoring prostate health.
Patients who have previously undergone cancer treatment and wish to monitor the condition's progression.